CompletedPhase 4

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

218 participantsStarted 2004-06

Plain-language summary

Antithyroid drugs are widely used in treatment of Graves' disease (GD), but after therapy withdrawal, relapse rate is very high. The aim this trail is to evaluate the effects of intrathyroid injection of dexamethasone combined with antithyroid drugs on patients with newly diagnosed GD.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Newly diagnosed of Graves' Disease Exclusion Criteria: * Pregnancy * Allergy to ATD, Alanine aminotransferase (ALT) or asparate aminotransferase (AST) above 2 times of upper normal range * Non-compliance because of psychiatric or other serious diseases, or unwillingness to participate in the study.

What they're measuring

relapse of hyperthyroidism

Timeframe: 4.5 year

Trial details

NCT IDNCT00917241

SponsorXiao-Ming Mao

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-12

View on ClinicalTrials.gov More Graves' Disease trials